Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes

Diabetes

Volumn 60, Issue 4, 2011, Pages 1237-1245

  Fourlanos, Spiros ^a,b,c   Perry, Christine ^b   Gellert, Shane A ^c   Martinuzzi, Emanuela ^d,e   Mallone, Roberto ^d,e   Butler, Jeanne ^a   Colman, Peter G ^c   Harrison, Leonard C ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GAMMA INTERFERON; GLUCOSE; HUMAN INSULIN; INSULIN; PANCREAS ISLET CELL ANTIBODY; PLACEBO; RECOMBINANT HUMAN INSULIN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; CELL FUNCTION; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RESPONSE; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ADMINISTRATION, INTRANASAL; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNE TOLERANCE; INSULIN; INSULIN ANTIBODIES; MALE; MIDDLE AGED; PLACEBOS; T-LYMPHOCYTES;

EID: 79953220761     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1360     Document Type: Article

References (28)

1. Narendran P, Mannering SI, Harrison LC. Proinsulin-a pathogenic autoantigen in type 1 diabetes. Autoimmun Rev 2003;2:204-210 (Pubitemid 36793944)
2. Nakayama M, Abiru N, Moriyama H, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005;435:220-223 (Pubitemid 40685949)
3. Krishnamurthy B, Dudek NL, McKenzie MD, et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006;116:3258-3265 (Pubitemid 44878640)
4. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-933 (Pubitemid 26225509)
5. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004;114:589-597 (Pubitemid 39572109)
6. Harrison LC, Hafler DA. Antigen-specific therapy for autoimmune disease. Curr Opin Immunol 2000;12:704-711
7. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991;88:10252-10256 (Pubitemid 21915813)
8. Bergerot I, Fabien N, Maguer V, Thivolet C. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. J Autoimmun 1994;7:655-663 (Pubitemid 24327697)
9. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulindependent diabetes. J Exp Med 1996;184:2167-2174
10. Pozzilli P, Pitocco D, Visalli N, et al.; IMDIAB Group. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). Diabetologia 2000;43:1000-1004
11. Chaillous L, Lefèvre H, Thivolet C, et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. Lancet 2000; 356:545-549 (Pubitemid 30611859)
12. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-1076 (Pubitemid 40616615)
13. Heinemann L, Jacques Y. Oral insulin and buccal insulin: a critical reappraisal. J Diabetes Sci Tech 2009;3:568-584
14. Harrison LC, Honeyman MC, Steele CE, et al. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 2004;27:2348-2355 (Pubitemid 39281384)
15. Näntö-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008;372:1746-1755
16. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005;48:2206-2212 (Pubitemid 41618908)
17. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
18. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al.; Type 1 Diabetes Trial Net Research GroupEuropean C-Peptide Trial Study Group. Mixedmeal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008;31:1966-1971
19. Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen- 2. Diabetologia 2008;51:846-852
20. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novel microassay for insulin autoantibodies. J Autoimmun 1997;10:473-478
21. Cowley DJ, Mackin RB. Expression, purification and characterization of recombinant human proinsulin. FEBS Lett 1997;402:124-130 (Pubitemid 27078243)
22. Martinuzzi E, Scotto M, Enée E, et al. Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection. J Immunol Methods 2008;333:61-70
23. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop Reference Protocol for the HLA DNA-Typing Technique. Oxford, Oxford University Press, 1992
24. Varney MD, Kanaan C, Tait BD. Identification of DRB1*0422 - implications for serological epitopes. Tissue Antigens 1996;47:150-152
25. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663-4670 (Pubitemid 24134427)
26. Waldo FB, van den Wall Bake AWL, Mestecky J, Husby S. Suppression of the immune response by nasal immunization. Clin Immunol Immunopathol 1994;72:30-34 (Pubitemid 24227333)
27. Mannering SI, Pang SH, Williamson NA, et al. The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. Clin Exp Immunol 2009;156:226-231
28. Achenbach P, Barker J, Bonifacio E; Pre-POINT Study Group. Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization. Curr Diab Rep 2008:8;87-93